Cargando…

Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report

BACKGROUND: Mycobacterium iranicum has recently been recognised as an opportunistic human pathogen. Although infectious conditions represent frequent triggers for hemophagocytic lymphohistiocytosis, non-tuberculous mycobacterial infections are rarely associated with this entity. To this date, M. ira...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandjean Lapierre, Simon, Toro, Alexandre, Drancourt, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549388/
https://www.ncbi.nlm.nih.gov/pubmed/28789664
http://dx.doi.org/10.1186/s13104-017-2684-8
_version_ 1783255969308868608
author Grandjean Lapierre, Simon
Toro, Alexandre
Drancourt, Michel
author_facet Grandjean Lapierre, Simon
Toro, Alexandre
Drancourt, Michel
author_sort Grandjean Lapierre, Simon
collection PubMed
description BACKGROUND: Mycobacterium iranicum has recently been recognised as an opportunistic human pathogen. Although infectious conditions represent frequent triggers for hemophagocytic lymphohistiocytosis, non-tuberculous mycobacterial infections are rarely associated with this entity. To this date, M. iranicum infection has never been reported in France, has never been associated with hemophagocytic lymphohistiocytosis and has never been found to be multi-resistant on standardized antimicrobial susceptibility testing. CASE PRESENTATION: We report a case of a French Caucasian man with secondary hemophagocytic lymphohistiocytosis in the context of M. iranicum bacteraemia and Hodgkin’s disease. We review available data concerning M. iranicum antimycobacterial susceptibility testing and treatment outcomes. We also review the association between hemophagocytic lymphohistiocytosis and non-tuberculous mycobacterial infections. CONCLUSION: Interpretation of M. iranicum positive cultures remains a clinical challenge and non-tuberculous mycobacterial infections need to be considered in secondary hemophagocytic lymphohistiocytosis differential diagnosis.
format Online
Article
Text
id pubmed-5549388
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55493882017-08-11 Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report Grandjean Lapierre, Simon Toro, Alexandre Drancourt, Michel BMC Res Notes Case Report BACKGROUND: Mycobacterium iranicum has recently been recognised as an opportunistic human pathogen. Although infectious conditions represent frequent triggers for hemophagocytic lymphohistiocytosis, non-tuberculous mycobacterial infections are rarely associated with this entity. To this date, M. iranicum infection has never been reported in France, has never been associated with hemophagocytic lymphohistiocytosis and has never been found to be multi-resistant on standardized antimicrobial susceptibility testing. CASE PRESENTATION: We report a case of a French Caucasian man with secondary hemophagocytic lymphohistiocytosis in the context of M. iranicum bacteraemia and Hodgkin’s disease. We review available data concerning M. iranicum antimycobacterial susceptibility testing and treatment outcomes. We also review the association between hemophagocytic lymphohistiocytosis and non-tuberculous mycobacterial infections. CONCLUSION: Interpretation of M. iranicum positive cultures remains a clinical challenge and non-tuberculous mycobacterial infections need to be considered in secondary hemophagocytic lymphohistiocytosis differential diagnosis. BioMed Central 2017-08-08 /pmc/articles/PMC5549388/ /pubmed/28789664 http://dx.doi.org/10.1186/s13104-017-2684-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Grandjean Lapierre, Simon
Toro, Alexandre
Drancourt, Michel
Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
title Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
title_full Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
title_fullStr Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
title_full_unstemmed Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
title_short Mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
title_sort mycobacterium iranicum bacteremia and hemophagocytic lymphohistiocytosis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549388/
https://www.ncbi.nlm.nih.gov/pubmed/28789664
http://dx.doi.org/10.1186/s13104-017-2684-8
work_keys_str_mv AT grandjeanlapierresimon mycobacteriumiranicumbacteremiaandhemophagocyticlymphohistiocytosisacasereport
AT toroalexandre mycobacteriumiranicumbacteremiaandhemophagocyticlymphohistiocytosisacasereport
AT drancourtmichel mycobacteriumiranicumbacteremiaandhemophagocyticlymphohistiocytosisacasereport